Monoclonal Mouse anti‑Human Alpha‑Fetoprotein Antibody (clone 2L6, IHC, IF, WB) LS‑C763899
Monoclonal Mouse anti‑Human Alpha‑Fetoprotein Antibody (clone 2L6, IHC, IF, WB) LS‑C763899
Antibody:
Alpha-Fetoprotein Mouse anti-Human Monoclonal (2L6) Antibody
Application:
IHC-P, IF, WB
Format:
Unconjugated, Unmodified
Overview
Antibody:
Alpha-Fetoprotein Mouse anti-Human Monoclonal (2L6) Antibody
Application:
IHC-P, IF, WB
Format:
Unconjugated, Unmodified
Specifications
Description
Alpha-Fetoprotein antibody LS-C763899 is an unconjugated mouse monoclonal antibody to human Alpha-Fetoprotein. Validated for IF, IHC and WB.
Target
Human Alpha-Fetoprotein
Synonyms
AFP | Alpha-1-fetoprotein | Alpha-fetoprotein | HPAFP | Alpha-fetoglobulin | FETA
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein A purification
Immunogen
Synthetic peptide
Applications
- IHC - Paraffin
- Immunofluorescence (1:100 - 1:300)
- Western blot (1:500 - 1:3000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.4., 0.02% Sodium Azide, 50% Glycerol
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Mouse
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 1/4/2025